Web based platform that provides powerful drug insights using annotated data from curated clinical trials results and structured real world evidence. Powered by the proprietary RxFilter® data optimization technology, Evidex features on-demand pooled analyses, predictive identification of serious unknown risks, direct downstream medical costs calculation, and drug safety scorecards.
Custom advisory services to aid market access and commercialization strategies using annotated data from curated clinical trials results and structured real world data. Support new drug launches, defend market position and help pharmaceutical companies tell their evidence based story.
Clean, standardized data architecture and straight forward APIs help power leading enterprise software applications and innovative IT companies to feed drug evidence and data into EHRs or third party applications.
Comparative research that provides evidence reviews of new and soon-to-be
launched drugs, insight into labeling changes and FDA safety communications, and evidence driven insight into other key drug issues.
Utilizing concise and detailed insight provided by Advera Health Analytics, your organization is able to gather and analyze large pools of information for pharmacy and therapeutics (P&T) class reviews, quantify downstream medical costs of drug side effects and perform side-by-side in-class drug comparisons. The use of both annotated data from curated clinical trial results and real world evidence to understand the true comparative nature of newly released drugs enables confident drug utilization recommendations. Quantifying the impact of downstream medical costs that result from drug side effects on total cost of care provides insight into the economic impact of P&T decisions.Learn more
Advera Health Analytics provides your organization with standardized and sourced annotated data from curated clinical trial results and real world evidence for a global evidence perspective. Advera Health’s data, analytics and insight provides the ability to quickly make evidence based drug utilization decisions, without the need for time consuming literature searches. Adverse event call centers and point-of-care clinical pharmacists can efficiently benchmark in-facility reported adverse event data to a global dataset making it possible to know if adverse events are an isolated incident or a part of an emerging trend. Advera Health’s insights will enable you to quickly determine immediate Pharmacy Department needs and protocols.Learn more
Advera Health Analytics’ data, analytics and insight provides a complete understanding of the true comparative nature of drugs through access to annotated data from curated clinical trial results and real world evidence. Statistical safety rankings and the ability to predict future regulatory action provide for critical information when positioning a drug to managed care. Advera Health’s tools provide comparative effectiveness analytics as well as detailed insight into emerging side effect trends for both your and your competitor’s products, ensuring better overall planning and positioning and more thorough due diligence for strategic investing and licensing. The knowledge of emerging side effect trends and thorough comparative assessments will enable you to appropriately position the risks and advantages of a particular candidate in today’s market and provide accurate and complete Comparative Effectiveness Research for the Pharmacy and Therapeutics (P&T) committees, using independent and trusted sources of data.Learn more
Utilizing simple to use and understand, statistical risk assessment analytics found in Advera Health Analytics’ products enables an enterprise-wide solution that provides you with a complete understanding of your life science business. By aggregating the risk from drug side effects, Advera is able to provide insight that reveals where risk exposure lies at the company and portfolio level, for example potential litigation, so vital when making underwriting decisions. The real world data, analytics and insight provided by Advera Health Analytics is insurance for your underwriting.Learn more
We live in a world where information is power. But the ability to use real world data is extremely difficult. Advera Health Analytics has developed proprietary analytics that provide quick access to both annotated data from curated clinical trial results and real world evidence, creating an information advantage for financial firms. Advera Health’s detailed insight also help you generate new investment ideas, and modify existing positions – all based on the most complete compilation of clinical evidence and real world evidence available.Learn more
The proprietarty RxFilter® data optimization technology was designed to take clinical and real world datasets and provide the most reliable, consistent, and accurate data for our analytics.
Peer reviewed by the journal Drug Safety, RxSignal® is a predictive algorithm that alerts users to emerging and/or previously unidentified side effect threats that may prompt a future FDA regulatory action.
Peer reviewed by the Journal of Managed Care and Specialty Pharmacy (JMCP), RxCost® and RxScore® encompass the first drug safety rating system based on costs from adverse events and patient outcomes.